Position in HLN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$727
-$17,451 QoQ
Shares Held
78
-95.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#610
of 639 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LRI Investments, LLC holds $288,012 across 22 Drug Manufacturers - Specialty & Generic names. HLN ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,143 | $106,484 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
151 | $81,815 | |
| 3 | ZTS |
Zoetis Inc.
|
246 | $17,677 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
349 | $16,497 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
427 | $14,804 | |
| 6 | VTRS |
Viatris Inc
|
737 | $11,703 | |
| 7 | PRGO |
PERRIGO Co plc
|
1,087 | $11,293 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
303 | $7,456 |
All Filings in HLN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $727 | 78 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $18,178 | 1,816 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $11,181 | 1,106 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $14,145 | 1,577 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $19,132 | 1,845 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $18,985 | 1,845 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $17,601 | 1,845 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,520 | 1,845 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $15,239 | 1,845 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $3,998 | 471 | Shares | Sole | 2024-05-21 | |
| No filing history on record for this holder in this stock. | ||||||